I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Outcomes and prognostic factors in initially unresectable h..:
Xingzhi Li
;
Jie Chen
;
Xiaobo Wang
...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1110689/full. , 2023
Link:
https://doi.org/10.3389/fonc.2023.1110689
RT Journal T1
Outcomes and prognostic factors in initially unresectable hepatocellular carcinoma treated using conversion therapy with lenvatinib and TACE plus PD-1 inhibitors
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:ef3d8a7f44ef49aa9df0d8198ccebd86&Exemplar=1&LAN=DE A1 Xingzhi Li A1 Jie Chen A1 Xiaobo Wang A1 Tao Bai A1 Shaolong Lu A1 Tao Wei A1 Zhihong Tang A1 Chengwen Huang A1 Bin Zhang A1 Bowen Liu A1 Lequn Li A1 Feixiang Wu PB Frontiers Media S.A. YR 2023 K1 conversion therapy K1 PD-1 inhibitors K1 initially unresectable hepatocellular carcinoma K1 transcatheter arterial chemoembolization K1 lenvatinib K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.frontiersin.org/articles/10.3389/fonc.2023.1110689/full LK http://dx.doi.org/https://doi.org/10.3389/fonc.2023.1110689 DO https://doi.org/10.3389/fonc.2023.1110689 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)